StockMacro
Company, fund or insider

Help

Menu

Phreesia

$11.41 +27% in 6 monthsMarket cap $708.2M

PHR on XNYS, Services, Phreesia, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue rose 13% to $507.8M over 12 months but the stock fell 40% in the same year.

  • GoodLatest quarter revenue rose 10% to $129.5M
  • WatchNews coverage: 8 articles in 7 days, 8.0 times its usual level

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 31 Jul 2026

Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.

Industry
Services-business services, nec (Services)
Employees
1,789
Website
phreesia.com
Listed
NYSE, US
Last results
2 Sep 2026
Next results
expected around 7 Dec 2026 (an estimate: a year ago it reported on 8 Dec 2025)
Revenue and net income per quarter. Quarter to 31 Jul 2026: revenue $129.5M, net income $1.9M.
Quarter to 31 Jan 2022: revenue $58.0M, net income -$46.5MQuarter to 31 Jan 2022: revenue $58.0M, net income -$46.5MQuarter to 30 Apr 2022: revenue $63.4M, net income -$51.2MQuarter to 30 Apr 2022: revenue $63.4M, net income -$51.2MQuarter to 31 Jul 2022: revenue $67.9M, net income -$46.7MQuarter to 31 Jul 2022: revenue $67.9M, net income -$46.7MQuarter to 31 Oct 2022: revenue $73.1M, net income -$40.2MQuarter to 31 Oct 2022: revenue $73.1M, net income -$40.2MQuarter to 31 Jan 2023: revenue $76.6M, net income -$38.0MQuarter to 31 Jan 2023: revenue $76.6M, net income -$38.0MQuarter to 30 Apr 2023: revenue $83.8M, net income -$37.5MQuarter to 30 Apr 2023: revenue $83.8M, net income -$37.5MQuarter to 31 Jul 2023: revenue $85.8M, net income -$36.8MQuarter to 31 Jul 2023: revenue $85.8M, net income -$36.8MQuarter to 31 Oct 2023: revenue $91.6M, net income -$31.9MQuarter to 31 Oct 2023: revenue $91.6M, net income -$31.9MQuarter to 31 Jan 2024: revenue $95.0M, net income -$30.6MQuarter to 31 Jan 2024: revenue $95.0M, net income -$30.6MQuarter to 30 Apr 2024: revenue $101.2M, net income -$19.7MQuarter to 30 Apr 2024: revenue $101.2M, net income -$19.7MQuarter to 31 Jul 2024: revenue $102.1M, net income -$18.0MQuarter to 31 Jul 2024: revenue $102.1M, net income -$18.0MQuarter to 31 Oct 2024: revenue $106.8M, net income -$14.4MQuarter to 31 Oct 2024: revenue $106.8M, net income -$14.4MQuarter to 31 Jan 2025: revenue $109.7M, net income -$6.4MQuarter to 31 Jan 2025: revenue $109.7M, net income -$6.4MQuarter to 30 Apr 2025: revenue $115.9M, net income -$3.9MQuarter to 30 Apr 2025: revenue $115.9M, net income -$3.9MQuarter to 31 Jul 2025: revenue $117.3M, net income $654KQuarter to 31 Jul 2025: revenue $117.3M, net income $654KQuarter to 31 Oct 2025: revenue $120.3M, net income $4.3MQuarter to 31 Oct 2025: revenue $120.3M, net income $4.3MQuarter to 31 Jan 2026: revenue $127.1M, net income $1.3MQuarter to 31 Jan 2026: revenue $127.1M, net income $1.3MQuarter to 30 Apr 2026: revenue $130.9M, net income $3.0MQuarter to 30 Apr 2026: revenue $130.9M, net income $3.0MQuarter to 31 Jul 2026: revenue $129.5M, net income $1.9MQuarter to 31 Jul 2026: revenue $129.5M, net income $1.9M
31 Jan 2022RevenueNet incomeNet losstallest bar $130.9M31 Jul 2026
See the numbers
Quarter toRevenueNet income
31 Jul 2026$129.5M$1.9M
30 Apr 2026$130.9M$3.0M
31 Jan 2026$127.1M$1.3M
31 Oct 2025$120.3M$4.3M
31 Jul 2025$117.3M$654K
30 Apr 2025$115.9M-$3.9M
31 Jan 2025$109.7M-$6.4M
31 Oct 2024$106.8M-$14.4M
31 Jul 2024$102.1M-$18.0M
30 Apr 2024$101.2M-$19.7M
31 Jan 2024$95.0M-$30.6M
31 Oct 2023$91.6M-$31.9M
31 Jul 2023$85.8M-$36.8M
30 Apr 2023$83.8M-$37.5M
31 Jan 2023$76.6M-$38.0M
31 Oct 2022$73.1M-$40.2M
31 Jul 2022$67.9M-$46.7M
30 Apr 2022$63.4M-$51.2M
31 Jan 2022$58.0M-$46.5M
Fundamentals, 12 months to 31 Jul 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $507.8M $449.7M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +13% +9.7%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $10.4M -$24.1M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $0.17 -$0.42
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 40.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 2.5% -5.8% 7.8%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 2.1% -5.3% 5.9%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 3.1% 10.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $80.7M $43.0M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $74.6M $98.3M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $66.4M $11.7M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$8.2M (net cash) -$86.6M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.18 0.57
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $5.99
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 67.8 25.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 1.4 1.5
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 1.4 1.8
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.9 2.4

Latest = 12 months to 31 Jul 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
PhreesiaPHR (this company) $708.2M67.81.4+13%2.1%
Cass Information SystemsCASS $669.2M17.53.3+5.4%18.9%
Priority TechnologyPRTH $650.7M16.00.63+10%4.0%
MediaAlphaMAX $784.0M7.30.61+15%8.4%
PaysignPAYS $556.6M27.45.1+47%18.5%
Liquidity ServicesLQDT $1.0B26.82.1+0.3%7.8%

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+10%

$129.5M vs $117.3M (quarter ended 31 Jul 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-72%

$492K vs $1.8M (quarter ended 31 Jul 2026)

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$66K

bought $682, sold $67K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+2.3%

227 13F filers vs 222

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

91%

56.3M shares held by 13F filers (30 Sep 2026) of 62.1M outstanding (27 Aug 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.9%

3.0M shares sold short (30 Oct 2026) of 62.1M outstanding (27 Aug 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.3

3.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-1.9%

3.1M shares sold short in the report before, 3.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

34%

34% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 43%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

8

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$240K

4 quarters

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

8

8 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

8.0×

8 articles in the last 7 days; its usual week has 1.

Price $11.41 on 20 Nov 2026, -40% over 12 months (12-month range $8.06 to $20.62)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders bought a net $26.8M in the last 12 months (the 12 months before: -$20.7M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months, -67% on the 12 months before.
Revenue per quarter. Revenue $129.5M in the latest quarter, +10% on a year earlier.
Capital spending per quarter. Capital spending $492K in the latest quarter, -72% on a year earlier.
Institutional holders (13F filers). 227 13F filers reported holding it in the latest 13F quarter, +3.7% on a year earlier.
Lobbying spend. Lobbying spend: $240K published in the last 12 months, +26% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
16 Mar 20268-K and other filingsA major agreement ended
23 Feb 20268-K and other filingsDirector or officer change
23 Feb 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Nov 20258-K and other filingsCompleted an acquisition or asset sale
21 Apr 2025Sharp changeLobbying on a new issue: lobbying on a new issue: BUD, TAX (2025-03-31)
21 Apr 2025Lobbying filingnew lobbying registration (TARPLIN, DOWNS & YOUNG, LLC)
15 Apr 2025Lobbying filinglobbying engagement terminated (FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC))
20 Jun 20248-K and other filingsDirector or officer change
20 Jun 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Dec 20238-K and other filingsA major agreement ended
5 Dec 20238-K and other filingsDirector or officer change
5 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
13 Jul 20238-K and other filingsDirector or officer change
13 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
16 May 2023Sharp changeMany funds opening a new position: many funds opening a new position, 38 vs usual 27 (2023-03-31); 1.5x the same period a year earlier
22 Mar 20238-K and other filingsDirector or officer change
22 Mar 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
18 Jan 2023Sharp changeLobbying on a new issue: lobbying on a new issue: MMM (2022-12-31)
22 Nov 2022Lobbying filingnew lobbying registration (FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC))
30 Aug 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.7M (2022-08-15); 1.5x the same period a year earlier
16 Aug 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.7M (2022-07-29); 1.3x the same period a year earlier
15 Jul 2022Lobbying filinglobbying engagement terminated (IMPACT HEALTH POLICY PARTNERS)
14 Jun 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.7M (2022-05-31); 1.4x the same period a year earlier
31 May 2022Sharp changeShort interest spike: short interest spike, 2.7M vs usual 1.6M (2022-05-13); 1.4x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 2.7M vs usual 1.6M (2022-04-29); 1.7x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 2.6M vs usual 1.6M (2022-04-14); 1.5x the same period a year earlier
14 Dec 2021Sharp changeQuarterly revenue change: quarterly revenue change, 55.9M vs usual 36.7M (2021-10-31); 1.5x the same period a year earlier
14 Dec 2021Sharp changeQuarterly capital spending jump: quarterly capital spending jump, 11.6M vs usual 2.1M (2021-10-31); 6.5x the same period a year earlier
Insider net buying (open market)
Month from 1 Jan 2022: -$73K published
Month from 1 May 2022: -$101K published
Month from 1 Jun 2022: -$127K published
Month from 1 Jul 2022: -$102K published
Month from 1 Sep 2022: -$73K published
Month from 1 Oct 2022: -$27K published
Month from 1 Nov 2022: -$519K published
Month from 1 Dec 2022: -$1.9M published
Month from 1 Jan 2023: -$337K published
Month from 1 Feb 2023: -$2.1M published
Month from 1 Apr 2023: -$967K published
Month from 1 May 2023: -$107K published
Month from 1 Jul 2023: -$34K published
Month from 1 Sep 2023: -$683K published
Month from 1 Oct 2023: -$189K published
Month from 1 Nov 2023: -$4K published
Month from 1 Dec 2023: -$9K published
Month from 1 Jan 2024: -$4.7M published
Month from 1 Feb 2024: -$40K published
Month from 1 Mar 2024: -$706K published
Month from 1 Apr 2024: -$1.5M published
Month from 1 May 2024: -$6K published
Month from 1 Jun 2024: -$5K published
Month from 1 Jul 2024: -$374K published
Month from 1 Aug 2024: -$367K published
Month from 1 Sep 2024: -$499K published
Month from 1 Oct 2024: -$293K published
Month from 1 Dec 2024: -$2.8M published
Month from 1 Jan 2025: -$4.9M published
Month from 1 Feb 2025: -$2.4M published
Month from 1 Mar 2025: -$142K published
Month from 1 Apr 2025: -$1.5M published
Month from 1 May 2025: -$3K published
Month from 1 Jun 2025: -$373K published
Month from 1 Jul 2025: -$1.2M published
Month from 1 Aug 2025: -$6.4M published
Month from 1 Sep 2025: -$594K published
Month from 1 Oct 2025: -$228K published
Month from 1 Dec 2025: -$8K published
Month from 1 Jan 2026: -$1.4M published
Month from 1 Mar 2026: $18.2M published
Month from 1 Apr 2026: $10.1M published
Month from 1 May 2026: -$4K published
Month from 1 Jun 2026: -$24K published
Month from 1 Jul 2026: -$34K published
Month from 1 Sep 2026: -$67K published
Month from 1 Oct 2026: $682 published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 2 published
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Oct 2022: 3 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Jan 2024: 1 published
Quarter from 1 Apr 2024: 1 published
Quarter from 1 Jul 2024: 2 published
Quarter from 1 Apr 2025: 2 published
Quarter from 1 Jul 2025: 1 published
Quarter from 1 Oct 2025: 3 published
Quarter from 1 Jul 2026: 1 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Oct 2021: $55.9M, +45% on a year earlier; public on 10 Dec 2021
Quarter ended 31 Jan 2022: $58.0M, +39% on a year earlier; public on 1 Apr 2022
Quarter ended 30 Apr 2022: $63.4M, +31% on a year earlier; public on 4 Jun 2022
Quarter ended 31 Jul 2022: $67.9M, +33% on a year earlier; public on 9 Sep 2022
Quarter ended 31 Oct 2022: $73.1M, +31% on a year earlier; public on 10 Dec 2022
Quarter ended 31 Jan 2023: $76.6M, +32% on a year earlier; public on 24 Mar 2023
Quarter ended 30 Apr 2023: $83.8M, +32% on a year earlier; public on 2 Jun 2023
Quarter ended 31 Jul 2023: $85.8M, +26% on a year earlier; public on 8 Sep 2023
Quarter ended 31 Oct 2023: $91.6M, +25% on a year earlier; public on 7 Dec 2023
Quarter ended 31 Jan 2024: $95.0M, +24% on a year earlier; public on 16 Mar 2024
Quarter ended 30 Apr 2024: $101.2M, +21% on a year earlier; public on 1 Jun 2024
Quarter ended 31 Jul 2024: $102.1M, +19% on a year earlier; public on 6 Sep 2024
Quarter ended 31 Oct 2024: $106.8M, +17% on a year earlier; public on 10 Dec 2024
Quarter ended 31 Jan 2025: $109.7M, +15% on a year earlier; public on 14 Mar 2025
Quarter ended 30 Apr 2025: $115.9M, +15% on a year earlier; public on 29 May 2025
Quarter ended 31 Jul 2025: $117.3M, +15% on a year earlier; public on 6 Sep 2025
Quarter ended 31 Oct 2025: $120.3M, +13% on a year earlier; public on 10 Dec 2025
Quarter ended 31 Jan 2026: $127.1M, +16% on a year earlier; public on 1 Apr 2026
Quarter ended 30 Apr 2026: $130.9M, +13% on a year earlier; public on 29 May 2026
Quarter ended 31 Jul 2026: $129.5M, +10% on a year earlier; public on 4 Sep 2026
Capital spending per quarter
Quarter ended 31 Oct 2021: $11.6M, +549% on a year earlier; public on 10 Dec 2021
Quarter ended 31 Jan 2022: $1.8M, -62% on a year earlier; public on 1 Apr 2022
Quarter ended 30 Apr 2022: $1.8M, -55% on a year earlier; public on 4 Jun 2022
Quarter ended 31 Jul 2022: $849K, -19% on a year earlier; public on 9 Sep 2022
Quarter ended 31 Oct 2022: $1.4M, -88% on a year earlier; public on 10 Dec 2022
Quarter ended 31 Jan 2023: $704K, -61% on a year earlier; public on 24 Mar 2023
Quarter ended 30 Apr 2023: $1.3M, -25% on a year earlier; public on 2 Jun 2023
Quarter ended 31 Jul 2023: $755K, -11% on a year earlier; public on 6 Sep 2024
Quarter ended 31 Oct 2023: $1.2M, -11% on a year earlier; public on 10 Dec 2024
Quarter ended 31 Jan 2024: $2.5M, +250% on a year earlier; public on 16 Mar 2024
Quarter ended 30 Apr 2024: $876K, -35% on a year earlier; public on 1 Jun 2024
Quarter ended 31 Jul 2024: $4.4M, +486% on a year earlier; public on 6 Sep 2024
Quarter ended 31 Oct 2024: $616K, -50% on a year earlier; public on 10 Dec 2024
Quarter ended 31 Jan 2025: $2.8M, +13% on a year earlier; public on 14 Mar 2025
Quarter ended 30 Apr 2025: $3.5M, +300% on a year earlier; public on 29 May 2025
Quarter ended 31 Jul 2025: $1.8M, -60% on a year earlier; public on 6 Sep 2025
Quarter ended 31 Oct 2025: $3.3M, +431% on a year earlier; public on 10 Dec 2025
Quarter ended 31 Jan 2026: $2.6M, -8.3% on a year earlier; public on 1 Apr 2026
Quarter ended 30 Apr 2026: $4.3M, +23% on a year earlier; public on 29 May 2026
Quarter ended 31 Jul 2026: $492K, -72% on a year earlier; public on 4 Sep 2026
Institutional holders (13F filers)
31 Dec 2021 report: 164; public on 14 Feb 2022
31 Mar 2022 report: 168; public on 16 May 2022
30 Jun 2022 report: 152; public on 15 Aug 2022
30 Sep 2022 report: 166; public on 14 Nov 2022
31 Dec 2022 report: 167; public on 14 Feb 2023
31 Mar 2023 report: 193; public on 15 May 2023
30 Jun 2023 report: 182; public on 14 Aug 2023
30 Sep 2023 report: 161; public on 14 Nov 2023
31 Dec 2023 report: 179; public on 14 Feb 2024
31 Mar 2024 report: 185; public on 15 May 2024
30 Jun 2024 report: 169; public on 14 Aug 2024
30 Sep 2024 report: 185; public on 14 Nov 2024
31 Dec 2024 report: 185; public on 14 Feb 2025
31 Mar 2025 report: 212; public on 15 May 2025
30 Jun 2025 report: 215; public on 14 Aug 2025
30 Sep 2025 report: 219; public on 14 Nov 2025
31 Dec 2025 report: 217; public on 17 Feb 2026
31 Mar 2026 report: 237; public on 15 May 2026
30 Jun 2026 report: 222; public on 14 Aug 2026
30 Sep 2026 report: 227; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $50K published
Quarter from 1 Apr 2022: $50K published
Quarter from 1 Jul 2022: $40K published
Quarter from 1 Jan 2023: $20K published
Quarter from 1 Apr 2023: $30K published
Quarter from 1 Jul 2023: $40K published
Quarter from 1 Oct 2023: $40K published
Quarter from 1 Jan 2024: $40K published
Quarter from 1 Apr 2024: $40K published
Quarter from 1 Jul 2024: $30K published
Quarter from 1 Oct 2024: $30K published
Quarter from 1 Jan 2025: $30K published
Quarter from 1 Apr 2025: $40K published
Quarter from 1 Jul 2025: $60K published
Quarter from 1 Oct 2025: $60K published
Quarter from 1 Jan 2026: $60K published
Quarter from 1 Apr 2026: $60K published
Quarter from 1 Jul 2026: $60K published
Quarter from 1 Oct 2026: $60K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $682 (26 Oct 2026), higher than 99% of its own history.
  • Insider net buying (open market): Insiders bought a net $26.8M in the last 12 months (the 12 months before: -$20.7M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months, -67% on the 12 months before.
  • Revenue per quarter: Revenue $129.5M in the latest quarter, +10% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 1 sale, $67K; 1 purchase, $682. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
26 Oct 2026David LinetskyPresident, Network SolutionsBuy70$9.75$682Form 4
22 Sep 2026Allison C HoffmanGeneral Counsel & SecretarySellplanned in advance (10b5-1)6,662$10.08$67KForm 4
17 Jul 2026Yvonne HuiPrincipal Accounting OfficerSellplanned in advance (10b5-1)1,247$10.92$14KForm 4
16 Jul 2026Lisa Egbuonu-DavisDirectorSellplanned in advance (10b5-1)536$10.70$6KForm 4
7 Jul 2026Yvonne HuiPrincipal Accounting OfficerSellplanned in advance (10b5-1)1,371$10.84$15KForm 4
26 Jun 2026Lisa Egbuonu-DavisDirectorSellplanned in advance (10b5-1)2,546$9.53$24KForm 4
20 May 2026Yvonne HuiPrincipal Accounting OfficerSellplanned in advance (10b5-1)431$8.85$4KForm 4
21 Apr 2026Allison C HoffmanGeneral Counsel & SecretarySellplanned in advance (10b5-1)6,176$9.06$56KForm 4

227 institutions reported shares at the end of Q3 2026, 91% of the shares outstanding; 36 opened a position, 31 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Pale Fire Capital SE8.9M14.4%$92.2MNo change
BlackRock, Inc.7.1M11.5%$73.7M+112K+1.6%
Vanguard Portfolio Management LLC3.3M5.28%$33.9M+290K+9.7%
AQR Capital Management LLC2.7M4.30%$27.6M-480K-15%
Vanguard Capital Management LLC2.5M3.98%$25.5M-81K-3.2%
T. Rowe Price Investment Management, Inc.1.8M2.91%+512K+39%
State Street Corp1.6M2.55%$16.3M+4,308+0.3%
Acadian Asset Management LLC1.5M2.35%-143K-8.9%
Algert Global LLC1.4M2.22%$14.2M+171K+14%
Jacobs Levy Equity Management, Inc1.2M2.01%$12.9M+133K+12%

Company events

All 30 company events

In 12 months: 2 major agreements, 1 director or officer change, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
4 May 2026Signed a major agreementSame filing: took on new debt8-K
16 Mar 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
23 Feb 2026Director or officer change8-K
12 Nov 2025Signed a major agreement; Completed an acquisition or asset saleSame filing: took on new debt8-K
4 Sep 2025Signed a major agreement8-K
20 Jun 2024Director or officer change8-K
5 Dec 2023Director or officer change; Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
13 Jul 2023Director or officer change8-K

8 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 25%, Design & UX 12%, Legal, policy & compliance 12%, People & recruiting 12%.

PostedJobLocation
21 Nov 2026or earlierSenior Associate, Client Solutions- Network SolutionsNot stated
21 Nov 2026or earlierBusiness Development RepresentativeSales & business developmentRemote United States
21 Nov 2026or earlierDirector, Head of Sales OperationsSales & business developmentNot stated
21 Nov 2026or earlierLead StrategistNot stated
21 Nov 2026or earlierSenior Product CounselLegal, policy & complianceRemote United States
17 Nov 2026Senior UX Designer, MobileDesign & UXRemote United States
16 Nov 2026Staff/Principal EngineerRemote United States
28 Oct 2026Senior RecruiterPeople & recruitingRemote United States

Reported lobbying spend: $60K in Q3 2026, $60K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Mar 2025EndedFGS Global (US) LLC (Fka FGH Holdings LLC)for Phreesia, Inc.Lobbying related to patient reported quality measurementHealth issues, Medicare/MedicaidFiling
1 Mar 2025NewTarplin, Downs & Young, LLCfor PhreesiaMedicare innovation, patient engagementTaxation, Budget, Health issues, Medicare/MedicaidFiling
15 Oct 2022NewFGS Global (US) LLC (Fka FGH Holdings LLC)for Phreesia, Inc.Lobbying related to patient reported quality measurementHealth issues, Medicare/MedicaidFiling
15 Jun 2022EndedImpact Health Policy Partnersfor Phreesia, Inc.Issues relating to quality measurement and electronic health records.Health issuesFiling
1 Jun 2021NewImpact Health Policy Partnersfor Phreesia, Inc.Issues relating to quality measurement and electronic health records.Health issuesFiling

The 5 newest of 77 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

7 Jul 2021confirmed

Confirmed across sources Filings + Financials and Lobbying

Phreesia (PHR): reported revenue of $48.3M for the quarter ended 30 Apr 2021, 1.4× the same quarter last year, while it registered for federal lobbying for the first time in our data (Impact Health Policy Partners). Two unrelated kinds of activity within 28 days.

  • Financials: Quarterly revenue change, became public on 8 Jun 2021
  • Lobbying: First lobbying registration, became public on 7 Jul 2021
2019-04-30: $28.3M2019-07-31: $30.8M2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M
The quarter ended 30 Apr 2021 against the 8 quarters before it. this quarterearliernormal: $33.1M
See the evidence (2 changes)

Financials: Quarterly revenue change became public on 8 Jun 2021

Phreesia reported revenue of $48.3M for the quarter ended 30 Apr 2021, 1.4× the same quarter last year.

This period
$48.3M (the quarter ended 30 Apr 2021)
Normal quarter (median of 8 earlier)
$33.1M
Typical spread (median absolute deviation)
$2.1M
How far from its usual level
+4.6
Same quarter last year
$33.4M
History used
1,096 days
2019-04-30: $28.3M2019-07-31: $30.8M2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M
the quarter ended 30 Apr 20218 earlier quartersnormal: $33.1M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Lobbying: First lobbying registration became public on 7 Jul 2021

Phreesia registered for federal lobbying for the first time in our data (Impact Health Policy Partners).

Source coverage starts
6 Apr 2010
Earlier events of other kinds
0

"First" means first in our data: it fires only when the source's history began at least 365 days earlier.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 27 Oct 2026Insiders record

    Linetsky David (President, Network Solutions) bought 70 shares of PHR ($682) (dated 26 Oct 2026)

  2. 3 Apr 2026Insiders record

    Barta Jan (ten percent owner) and 4 other(s) bought 1,275,500 shares of PHR ($10.5M) (dated 2 Apr 2026)

  3. 20 Mar 2026Insiders record

    Pale Fire Capital SICAV a.s. (ten percent owner) and 4 other(s) bought 1,602,505 shares of PHR ($18.3M) (dated 19 Mar 2026)

  4. 16 Mar 2026Filings record

    A major agreement ended

  5. 23 Feb 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 23 Feb 2026Filings record

    Director or officer change

  7. 12 Nov 2025Filings record

    Completed an acquisition or asset sale

  8. 21 Apr 2025Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['BUD', 'TAX']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    6139464
  9. 21 Apr 2025Lobbying record

    PHREESIA: new lobbying registration (TARPLIN, DOWNS & YOUNG, LLC) (dated 1 Mar 2025)

  10. 15 Apr 2025Lobbying record

    PHREESIA, INC.: lobbying engagement terminated (FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)) (dated 31 Mar 2025)

  11. 20 Jun 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 20 Jun 2024Filings record

    Director or officer change

  13. 5 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 5 Dec 2023Filings record

    Director or officer change

  15. 5 Dec 2023Filings record

    A major agreement ended

  16. 13 Jul 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 13 Jul 2023Filings record

    Director or officer change

  18. 15 May 2023Institutional holdings change

    saw 38 13F filers open a new position in the quarter ended 31 Mar 2023, 1.5× the same quarter last year.

    Same quarter last year: 26; its normal quarter is 27.

    See the evidence
    This period
    38 (the quarter ended 31 Mar 2023)
    Normal quarter (median of 8 earlier)
    27
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +3.7
    Same quarter last year
    26
    History used
    1,278 days
    2021-03-31: 292021-06-30: 282021-09-30: 202021-12-31: 282022-03-31: 262022-06-30: 212022-09-30: 292022-12-31: 182023-03-31: 38
    the quarter ended 31 Mar 20238 earlier quartersnormal: 27

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  19. 22 Mar 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 22 Mar 2023Filings record

    Director or officer change

  21. 18 Jan 2023Lobbying change

    lobbying on a new issue.

    See the evidence
    New
    ['MMM']
    Rule
    only points whose every posting (and value revision) is at or before as_of
    Field
    issue_codes
    Metric
    lobbying.filings_count
    Point id
    12626509
  22. 22 Nov 2022Lobbying record

    PHREESIA, INC.: new lobbying registration (FGS GLOBAL (US) LLC (FKA FGH HOLDINGS LLC)) (dated 15 Oct 2022)

  23. 25 Aug 2022Short interest and volume change

    had 2.6M shares sold short in the 15 Aug 2022 report, 1.5× the same report last year.

    Same report last year: 1.8M; its normal report is 1.7M.

    See the evidence
    This period
    2.6M (the 15 Aug 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +3.9
    Same report last year
    1.8M
    History used
    1,111 days
    2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M2022-04-29: 2.7M2022-05-13: 2.7M2022-05-31: 2.6M2022-06-15: 2.2M2022-06-30: 2.2M2022-07-15: 2.4M2022-07-29: 2.6M2022-08-15: 2.6M
    the 15 Aug 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 10 Aug 2022Short interest and volume change

    had 2.6M shares sold short in the 29 Jul 2022 report, 1.3× the same report last year.

    Same report last year: 1.9M; its normal report is 1.7M.

    See the evidence
    This period
    2.6M (the 29 Jul 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +3.9
    Same report last year
    1.9M
    History used
    1,094 days
    2021-07-15: 2.0M2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M2022-04-29: 2.7M2022-05-13: 2.7M2022-05-31: 2.6M2022-06-15: 2.2M2022-06-30: 2.2M2022-07-15: 2.4M2022-07-29: 2.6M
    the 29 Jul 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 15 Jul 2022Lobbying record

    PHREESIA, INC.: lobbying engagement terminated (IMPACT HEALTH POLICY PARTNERS) (dated 15 Jun 2022)

  26. 10 Jun 2022Short interest and volume change

    had 2.6M shares sold short in the 31 May 2022 report, 1.4× the same report last year.

    Same report last year: 1.8M; its normal report is 1.7M.

    See the evidence
    This period
    2.6M (the 31 May 2022 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    137K
    How far from its usual level
    +4.5
    Same report last year
    1.8M
    History used
    1,035 days
    2021-05-14: 1.9M2021-05-28: 1.8M2021-06-15: 1.9M2021-06-30: 2.0M2021-07-15: 2.0M2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M2022-04-29: 2.7M2022-05-13: 2.7M2022-05-31: 2.6M
    the 31 May 2022 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 May 2022Short interest and volume change

    had 2.7M shares sold short in the 13 May 2022 report, 1.4× the same report last year.

    Same report last year: 1.9M; its normal report is 1.6M.

    See the evidence
    This period
    2.7M (the 13 May 2022 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    122K
    How far from its usual level
    +5.6
    Same report last year
    1.9M
    History used
    1,017 days
    2021-04-30: 1.6M2021-05-14: 1.9M2021-05-28: 1.8M2021-06-15: 1.9M2021-06-30: 2.0M2021-07-15: 2.0M2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M2022-04-29: 2.7M2022-05-13: 2.7M
    the 13 May 2022 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 11 May 2022Short interest and volume change

    had 2.7M shares sold short in the 29 Apr 2022 report, 1.7× the same report last year.

    Same report last year: 1.6M; its normal report is 1.6M.

    See the evidence
    This period
    2.7M (the 29 Apr 2022 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    104K
    How far from its usual level
    +6.6
    Same report last year
    1.6M
    History used
    1,003 days
    2021-04-15: 1.7M2021-04-30: 1.6M2021-05-14: 1.9M2021-05-28: 1.8M2021-06-15: 1.9M2021-06-30: 2.0M2021-07-15: 2.0M2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M2022-04-29: 2.7M
    the 29 Apr 2022 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 27 Apr 2022Short interest and volume change

    had 2.6M shares sold short in the 14 Apr 2022 report, 1.5× the same report last year.

    Same report last year: 1.7M; its normal report is 1.6M.

    See the evidence
    This period
    2.6M (the 14 Apr 2022 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    104K
    How far from its usual level
    +5.8
    Same report last year
    1.7M
    History used
    988 days
    2021-03-31: 1.5M2021-04-15: 1.7M2021-04-30: 1.6M2021-05-14: 1.9M2021-05-28: 1.8M2021-06-15: 1.9M2021-06-30: 2.0M2021-07-15: 2.0M2021-07-30: 1.9M2021-08-13: 1.8M2021-08-31: 1.6M2021-09-15: 1.6M2021-09-30: 1.8M2021-10-15: 1.6M2021-10-29: 1.6M2021-11-15: 1.5M2021-11-30: 1.6M2021-12-15: 1.4M2022-01-14: 1.6M2022-01-31: 1.5M2022-02-15: 1.6M2022-02-28: 1.6M2022-03-15: 1.7M2022-03-31: 1.7M2022-04-14: 2.6M
    the 14 Apr 2022 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 14 Dec 2021Financials change

    reported revenue of $55.9M for the quarter ended 31 Oct 2021, 1.5× the same quarter last year.

    Same quarter last year: $38.5M; its normal quarter is $36.7M.

    See the evidence
    This period
    $55.9M (the quarter ended 31 Oct 2021)
    Normal quarter (median of 8 earlier)
    $36.7M
    Typical spread (median absolute deviation)
    $3.9M
    How far from its usual level
    +3.3
    Same quarter last year
    $38.5M
    History used
    1,280 days
    2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M2021-07-31: $51.0M2021-10-31: $55.9M
    the quarter ended 31 Oct 20218 earlier quartersnormal: $36.7M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  31. 14 Dec 2021Financials change

    spent $11.6M on capital projects in the quarter ended 31 Oct 2021, 6.5× the same quarter last year.

    Same quarter last year: $1.8M; its normal quarter is $2.1M.

    See the evidence
    This period
    $11.6M (the quarter ended 31 Oct 2021)
    Normal quarter (median of 8 earlier)
    $2.1M
    Typical spread (median absolute deviation)
    $480K
    How far from its usual level
    +9.4
    Same quarter last year
    $1.8M
    History used
    1,096 days
    2019-10-31: $2.1M2020-01-31: $2.2M2020-04-30: $1.9M2020-07-31: $2.7M2020-10-31: $1.8M2021-01-31: $4.8M2021-04-30: $4.0M2021-07-31: $1.0M2021-10-31: $11.6M
    the quarter ended 31 Oct 20218 earlier quartersnormal: $2.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $5.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 1 Oct 2021Filings record

    Director or officer change

  33. 7 Sep 2021Financials change

    reported revenue of $51.0M for the quarter ended 31 Jul 2021, 1.5× the same quarter last year.

    Same quarter last year: $35.0M; its normal quarter is $34.2M.

    See the evidence
    This period
    $51.0M (the quarter ended 31 Jul 2021)
    Normal quarter (median of 8 earlier)
    $34.2M
    Typical spread (median absolute deviation)
    $2.4M
    How far from its usual level
    +4.7
    Same quarter last year
    $35.0M
    History used
    1,188 days
    2019-07-31: $30.8M2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M2021-07-31: $51.0M
    the quarter ended 31 Jul 20218 earlier quartersnormal: $34.2M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  34. 20 Aug 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 20 Aug 2021Filings record

    Director or officer change

  36. 7 Jul 2021several at once

    reported revenue of $48.3M for the quarter ended 30 Apr 2021, 1.4× the same quarter last year, while it registered for federal lobbying for the first time in our data (Impact Health Policy Partners). Two unrelated kinds of activity within 28 days.

    See the evidence (2 changes)

    Financials: Quarterly revenue change became public on 8 Jun 2021

    Phreesia reported revenue of $48.3M for the quarter ended 30 Apr 2021, 1.4× the same quarter last year.

    This period
    $48.3M (the quarter ended 30 Apr 2021)
    Normal quarter (median of 8 earlier)
    $33.1M
    Typical spread (median absolute deviation)
    $2.1M
    How far from its usual level
    +4.6
    Same quarter last year
    $33.4M
    History used
    1,096 days
    2019-04-30: $28.3M2019-07-31: $30.8M2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M
    the quarter ended 30 Apr 20218 earlier quartersnormal: $33.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Lobbying: First lobbying registration became public on 7 Jul 2021

    Phreesia registered for federal lobbying for the first time in our data (Impact Health Policy Partners).

    Source coverage starts
    6 Apr 2010
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  37. 7 Jul 2021Lobbying change

    registered for federal lobbying for the first time in our data (Impact Health Policy Partners).

    See the evidence (1 source record)
    Source coverage starts
    6 Apr 2010
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  38. 7 Jul 2021Lobbying record

    PHREESIA, INC.: new lobbying registration (IMPACT HEALTH POLICY PARTNERS) (dated 1 Jun 2021)

  39. 8 Jun 2021Financials change

    reported revenue of $48.3M for the quarter ended 30 Apr 2021, 1.4× the same quarter last year.

    Same quarter last year: $33.4M; its normal quarter is $33.1M.

    See the evidence
    This period
    $48.3M (the quarter ended 30 Apr 2021)
    Normal quarter (median of 8 earlier)
    $33.1M
    Typical spread (median absolute deviation)
    $2.1M
    How far from its usual level
    +4.6
    Same quarter last year
    $33.4M
    History used
    1,096 days
    2019-04-30: $28.3M2019-07-31: $30.8M2019-10-31: $32.8M2020-01-31: $32.8M2020-04-30: $33.4M2020-07-31: $35.0M2020-10-31: $38.5M2021-01-31: $41.8M2021-04-30: $48.3M
    the quarter ended 30 Apr 20218 earlier quartersnormal: $33.1M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  40. 3 May 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 52 entries; narrow the window or the kind of data to see older ones.

Not listed: 430 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001412408
Ticker
PHR
Domain
phreesia.com
Employer name
Phreesia, Inc. (1 unverified)
Hq location
DE|WILMINGTON|19803 (1 unverified)
Lobbying client
phreesia
Name
AccessOne Funding, LLC, AccessOne Holdings, Inc, AccessOne MedCard, Inc, AccessOne Parent Holdings, Inc and 1 more
Wikidata
Q7188106
Wikipedia
Phreesia
  • DOL H-1B labor condition applications and PERM certifications179 data points1 Jul 2020 to 31 Aug 2026
  • Federal lobbying disclosures (LDA)5 records, 63 data points1 Jun 2021 to 30 Sep 2026
  • SEC Form 13F institutional holdings261 data points30 Sep 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)94 records8 Nov 2017 to 3 Sep 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)515 data points31 Jan 2017 to 27 Aug 2026
  • SEC Form 4 insider transactions359 records, 704 data points24 Jul 2019 to 26 Oct 2026
  • FINRA short interest (twice monthly)521 data points31 Jul 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3696 data points18 Jul 2019 to 20 Nov 2026
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026